Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anticoagulation for atrial fibrillation ablation: what is the optimal strategy?

× No keyword cloud information.

9 in total

1. Periprocedural dabigatran anticoagulation for atrial fibrillation ablation: do we have enough information to make a rational decision.

Authors: Amit Noheria; Samuel J Asirvatham
Journal: J Interv Card Electrophysiol Date: 2013-07-28 Impact factor: 1.900

Review 2. Highlights of the year in JACC 2012.

Authors: Anthony N DeMaria; Jeroen J Bax; Gregory K Feld; Barry H Greenberg; Jennifer L Hall; Mark A Hlatky; Wilbur Y W Lew; João A C Lima; Ehtisham Mahmud; Alan S Maisel; Sanjiv M Narayan; Steven E Nissen; David J Sahn; Sotirios Tsimikas
Journal: J Am Coll Cardiol Date: 2013-01-22 Impact factor: 24.094

3. Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter.

Authors: Daniel W Kaiser; Megan M Streur; Rangadham Nagarakanti; S Patrick Whalen; Christopher R Ellis
Journal: J Interv Card Electrophysiol Date: 2013-04-28 Impact factor: 1.900

4. Is dabigatran efficacy enough to prevent stroke in atrial fibrillation patient with high CHADS2 score during peri-procedural catheter radiofrequency ablation? A case report with literature review.

Authors: Xiang-Min Shi; Fu-Kun Chen; Zhuo Liang; Jian Li; Kun Lin; Jian-Ping Guo; Zhao-Liang Shan
Journal: Int J Clin Exp Med Date: 2015-04-15

5. A comparison of bleeding complications between warfarin, dabigatran, and rivaroxaban in patients undergoing cryoballoon ablation.

Authors: David Snipelisky; Jordan C Ray; Ryan Ung; Melissa Duart; Christine Kauffman; Fred Kusumoto
Journal: J Interv Card Electrophysiol Date: 2014-11-08 Impact factor: 1.900

6. Effectiveness and Safety of Idarucizumab for Periprocedural Cardiac Tamponade After Catheter Ablation of Atrial Fibrillation in Dabigatran Recipients: A Retrospective Controlled Study.

Authors: Langjing Huang; Zhihua Yu; Mei Liu; Xiaoke Shang
Journal: Am J Cardiovasc Drugs Date: 2022-06-18 Impact factor: 3.283

Review 7. Role of the new target specific oral anticoagulants in the management of anticoagulation for cardioversion and atrial fibrillation ablation.

Authors: Marcin Kowalski; Valay Parikh
Journal: J Thromb Thrombolysis Date: 2013-08 Impact factor: 2.300

8. A comparison of bleeding complications post-ablation between warfarin and dabigatran.

Authors: David Snipelisky; Christine Kauffman; Karin Prussak; Gretchen Johns; K Venkatachalam; Fred Kusumoto
Journal: J Interv Card Electrophysiol Date: 2012-08-07 Impact factor: 1.900

Review 9. Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation.

Authors: Ilir Maraj; Mario D Gonzalez; Gerald V Naccarelli
Journal: J Innov Card Rhythm Manag Date: 2018-08-15

9 in total